Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness

Abstract

A variant of the PTPN22-encoded Lyp phosphatase (Lyp620W) confers risk for autoimmune disease, but the mechanisms underlying this association remain unclear. We show here that mice expressing the Lyp variant homolog Pep619W manifest thymic and splenic enlargement accompanied by increases in T-cell number, activation and positive selection and in dendritic- and B-cell activation. Although Ptpn22 (Pep) transcript levels were comparable in Pep619W and wild-type Pep619R mice, Pep protein levels were dramatically reduced in the mutant mice, with Pep619W protein being more rapidly degraded and showing greater association with and in vitro cleavage by calpain 1 than Pep619R. Similarly, levels of the Lyp620W variant were decreased in human T and B cells, and its calpain binding and cleavage were increased relative to wild-type Lyp620R. Thus, calpain-mediated degradation with consequently reduced Lyp/Pep expression and lymphocyte and dendritic cell hyperresponsiveness represents a mechanism whereby Lyp620W may increase risk for autoimmune disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Enhanced T-cell activation in Pep619W mice.
Figure 2: Enhanced activation and function of B and dendritic cells from Pep619W mice.
Figure 3: Levels and stability of Pep are reduced in Pep619W mice.
Figure 4: Pep binding to and cleavage by calpain is increased in Pep619W mice.
Figure 5: Reduced stability and level of Lyp620W in human cells.
Figure 6: Lyp levels are reduced and activation is increased in peripheral blood mononuclear cells (PBMCs) from individuals homozygous for the PTPN22 risk allele.

Similar content being viewed by others

References

  1. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337–338 (2004).

    Article  CAS  Google Scholar 

  2. Begovich, A.B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330–337 (2004).

    Article  CAS  Google Scholar 

  3. Velaga, M.R. et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89, 5862–5865 (2004).

    Article  CAS  Google Scholar 

  4. van Oene, M. et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum. 52, 1993–1998 (2005).

    Article  CAS  Google Scholar 

  5. Cohen, S., Dadi, H., Shaoul, E., Sharfe, N. & Roifman, C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 96, 2013–2024 (1999).

    Google Scholar 

  6. Cloutier, J.F. & Veillette, A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15, 4909–4918 (1996).

    Article  CAS  Google Scholar 

  7. Gregorieff, A., Cloutier, J.F. & Veillette, A. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50 (csk). J. Biol. Chem. 273, 13217–13222 (1998).

    Article  CAS  Google Scholar 

  8. Ghose, R., Shekhtman, A., Goger, M.J., Ji, H. & Cowburn, D. A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat. Struct. Biol. 8, 998–1004 (2001).

    Article  CAS  Google Scholar 

  9. Cloutier, J.F. & Veillette, A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189, 111–121 (1999).

    Article  CAS  Google Scholar 

  10. Gjörloff-Wingren, A., Saxena, M., Williams, S., Hammi, D. & Mustelin, T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29, 3845–3854 (1999).

    Article  Google Scholar 

  11. Hill, R.J. et al. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp. Hematol. 30, 237–244 (2002).

    Article  CAS  Google Scholar 

  12. Hasegawa, K. et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303, 685–689 (2004).

    Article  CAS  Google Scholar 

  13. Lefvert, A.K. et al. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J. Neuroimmunol. 197, 110–113 (2008).

    Article  CAS  Google Scholar 

  14. Vang, T. et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37, 1317–1319 (2005).

    Article  CAS  Google Scholar 

  15. Rieck, M. et al. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 179, 4704–4710 (2007).

    Article  CAS  Google Scholar 

  16. Arechiga, A.F. et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol. 182, 3343–3347 (2009).

    Article  CAS  Google Scholar 

  17. Zikherman, J. et al. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182, 4093–4106 (2009).

    Article  CAS  Google Scholar 

  18. Villadangos, J.A. & Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7, 543–555 (2007).

    Article  CAS  Google Scholar 

  19. Leung, B.P. et al. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J. Immunol. 169, 7071–7077 (2002).

    Article  CAS  Google Scholar 

  20. Lowes, M.A. et al. Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 102, 19057–19062 (2005).

    Article  CAS  Google Scholar 

  21. Decker, P., Kötter, I., Klein, R., Berner, B. & Rammensee, H.G. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 45, 1087–1095 (2006).

    Article  CAS  Google Scholar 

  22. Chien, W. et al. Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway. J. Biol. Chem. 278, 27413–27420 (2003).

    Article  CAS  Google Scholar 

  23. Sandoval, A. et al. Two PEST-like motifs regulate Ca2+/calpain-mediated cleavage of the CaVβ3 subunit and provide important determinants for neuronal Ca2+ channel activity. Eur. J. Neurosci. 23, 2311–2320 (2006).

    Article  Google Scholar 

  24. Wang, N. et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111, 99–107 (2003).

    Article  CAS  Google Scholar 

  25. Mykles, D.L. Intracellular proteinases of invertebrates: calcium-dependent and proteasome/ubiquitin-dependent systems. Int. Rev. Cytol. 184, 157–289 (1998).

    Article  CAS  Google Scholar 

  26. Nagy, A., Gertsenstein, M., Vintersten, K. & Behringer, R. Isolation, culture, and manipulation of blastocyst–derived stem cells. Manipulating the Mouse Embryo: A Laboratory Manual 3rd edn. (ed. Inglis, J.) 359–398 (Cold Spring Harbor Laboratory Press, New York, 2003).

  27. Poueymirou, W.T. et al. F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat. Biotechnol. 25, 91–99 (2007).

    Article  CAS  Google Scholar 

  28. Naldini, L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457–463 (1998).

    Article  CAS  Google Scholar 

  29. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).

    Article  CAS  Google Scholar 

  30. Guttmann, R.P. et al. Specific proteolysis of the NR2 subunit at multiple sites by calpain. J. Neurochem. 78, 1083–1093 (2001).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the assistance of K. Carrington (Mount Sinai Hospital) and M. Keogh (The Feinstein Institute for Medical Research) in recruiting subjects for these studies, H. Yao and G. Jiang for their technical assistance, D. Davidson and A. Veillette (Institute de Recherches Cliniques de Montreal) for their generosity in providing Pep-specific antibody, and A. Goldman in manuscript preparation and review. This work was supported by grants from the Canadian Institute for Health Research (MOP10730 and MOP79321), the Canadian Arthritis Network (07-SRID-IJD-03) and the Ontario Research Fund (RE01-061). K.A.S. is supported by a Canada Research Chair and holds the Sherman Family Chair in Genomic Medicine.

Author information

Authors and Affiliations

Authors

Contributions

J.Z. and K.A.S. designed the study. N.Z. and B.D. performed most of the flow cytometry analyses. Q.J. and A.C.P. derived the knock-in mice. H.M. and S.H. carried out the calpain and ubiquitination analyses. X.M., G.X., F.Q. and Z.H. carried out and/or derived reagents for other protein and RNA analyses. E.C.K., J.Z. and K.A.S. obtained and/or analyzed the human samples. J.Z., C.A.M., E.C.K., A.C.P. and K.A.S. played key roles in data analysis and manuscript preparation.

Corresponding author

Correspondence to Katherine A Siminovitch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4 and Supplementary Table 1. (PDF 634 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, J., Zahir, N., Jiang, Q. et al. The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 43, 902–907 (2011). https://doi.org/10.1038/ng.904

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.904

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing